Skip to main content

Zantac Multidistrict Litigation Narrowed By Florida Judge

Zantac Multidistrict Litigation Narrowed By Florida Judge

Zantac Multidistrict Litigation Narrowed By Florida Judge

Introduction

The U.S. Racketeer Influenced and Corrupt Organizations Act (RICO) and medical monitoring claims in the Zantac litigation have been dismissed by U.S. District Judge Robin Rosenberg.

RICO and medical monitoring claims, which the judge dismissed, sought compensation for diagnostic tests that detect cancer. The judge even excluded the distributors and pharmacies, including Rite Aid and CVS, from the litigation and personal injury claims.

The court's ruling came as the federal court wants to focus the litigations more on the manufacturers, including Boehringer Ingelheim, GlaxoSmithKline, Sanofi-Aventis, and Pfizer Inc. A spokesperson for Pfizer said that the company is pleased with the judge's ruling.

The plaintiffs' attorney said that a vast majority of the claims would be in motion, and the ruling will impact 100,000 people who suffer from cancer caused due to the exposure to carcinogen NDMA present in Zantac.

The attorneys even argued that manufacturers including GlaxoSmithKline, Boehringer Ingelheim, and Sanofi tried to cover up the dangers and risks associated with Zantac usage even though there were sufficient pieces of evidence against the heartburn drug being linked to NDMA.

In 2019, the U.S. Food and Drug Administration identified that certain ranitidine medicines such as Zantac include a possible carcinogen, known as N-nitrosodimethylamine, or NDMA, post to which Sanofi removed Zantac from the market.

U.S. District Judge Robin L in Florida is overlooking the Zantac lawsuits under MDL No: 2924. Currently, more than 1,400 lawsuits are pending from the Zantac users contracted with cancer, and at least 70,000 more claims are recorded in the court against the drug.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!